AAOS2018: IV TXA reduced blood loss in total shoulder arthroplasty
Tranexamic Acid Reduces Blood Loss Following Primary Shoulder Arthroplasty: A Double- Blind Placebo-Controlled Prospective Randomized Controlled Trial
Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
CONFERENCE ACE REPORTS
This ACE Report is a summary of a conference presentation or abstract. The information provided has limited the ability to provide an accurate assessment of the risk of bias or the overall quality. Please interpret the results with caution as trials may be in progress and select results may have been presented.
110 patients scheduled for total shoulder arthroplasty were randomized to intravenous administration of either tranexamic acid or placebo saline. Patients were assessed for total blood loss, transfusion rate, hemoglobin loss, length of stay, and venous thromboembolic complications. Results demonstrated a significant reduction in total blood loss in the TXA group compared to the placebo group. Ther...
Learn about our AI Driven
High Impact Search Feature
The OE High Impact metric uses AI to determine the impact a study will have by considering the content of the article itself. Built using the latest advances of natural language processing techniques. OE High Impact predicts an article’s future number of citations than impact factor alone.Continue